Malhotra A K, Goldman D, Ozaki N, Rooney W, Clifton A, Buchanan R W, Breier A, Pickar D
Experimental Therapeutics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Neuroreport. 1996 Sep 2;7(13):2100-2. doi: 10.1097/00001756-199609020-00007.
The presence of the 5HT2C receptor allele, Ser23, has recently been reported to predict favorable response to the antipsychotic drug, clozapine. This finding is of interest as Ser23, compared with the more abundant Cys23, alters pharmacological characteristics of the receptor and therefore may provide insights into the mechanism of action of antipsychotic drugs. We determined 5HT2C receptor genotype at the Cys23Ser locus in 66 subjects participating in double-blind studies of clozapine. There was no relationship between Ser23 and clozapine response (p = 0.30, Fisher's exact) nor was there any effect of Ser23 upon absolute levels of psychiatric symptoms after 10 weeks of clozapine treatment (t = -0.57, p = 0.57). These data suggest that this 5HT2C receptor polymorphism is not associated with clozapine response.
最近有报道称,5HT2C受体等位基因Ser23的存在可预测对抗精神病药物氯氮平的良好反应。这一发现很有意思,因为与更为常见的Cys23相比,Ser23改变了受体的药理学特性,因此可能有助于深入了解抗精神病药物的作用机制。我们在参与氯氮平双盲研究的66名受试者中,测定了Cys23Ser位点的5HT2C受体基因型。Ser23与氯氮平反应之间没有关联(p = 0.30,Fisher精确检验),在氯氮平治疗10周后,Ser23对精神症状的绝对水平也没有任何影响(t = -0.57,p = 0.57)。这些数据表明,这种5HT2C受体多态性与氯氮平反应无关。